Peripheral artery disease and intermittent claudicationPeripheral arterial disease; PAD; Peripheral vascular disease
An in-depth report on the causes, diagnosis, and treatment of peripheral artery disease (PAD).
Peripheral Artery Disease
Peripheral artery disease (PAD) is a type of atherosclerosis, the condition that causes hardening of the arteries. PAD occurs when arteries in the limbs (most often the legs) become narrowed by cholesterol-rich material called plaque. Because PAD interferes with circulation, in severe cases procedures may be required to improve blood flow. When PAD is very severe, it can increase the risk for gangrene and can result in a need for amputation. Patients with PAD are also at increased risk for complications in other arteries, which can lead to heart attacks and stroke.
Risk Factors of PAD
The main risk factors of PAD include:
- Unhealthy cholesterol and lipid levels
- High blood pressure
- Advancing age
Many people with PAD do not have symptoms. When symptoms do occur, leg cramp pain (intermittent claudication) is the main symptom. At first, this symptom occurs with predictable amounts of exercise (walking a certain distance, up a hill or stairs), and disappears when at rest. When PAD becomes more severe, symptoms can include:
- Pain or tingling in the calf, feet, or toes, even at rest
- Weakened calf muscles
- Painful non-bleeding ulcers on the feet or toes that do not heal
Treatment for PAD includes both lifestyle measures and medications that help reduce symptoms and prevent disease progression. These include:
- Smoking cessation.
- Regular exercise, which is essential for patients with mild-to-moderate PAD.
- Heart-healthy diet, low in saturated fat and sodium, to reduce unhealthy cholesterol levels and improve blood pressure.
- Medications to help control high blood pressure and cholesterol. Other important drugs include antiplatelet medications to prevent blood clots.
- In severe cases, procedures may be needed to open blocked blood vessels.
Peripheral artery disease (PAD) occurs when the arteries in the extremities (usually legs and feet, sometimes arms and hands) become clogged with fat, cells, and other substances, which accumulate and harden into plaque. The build-up of plaque causes the arteries to become narrow and stiff, obstructing blood flow. This hardening and narrowing of the arteries is called atherosclerosis. (Atherosclerosis that affects arteries to the heart and brain is the major process leading to heart disease and stroke.)
PAD most often occurs in the legs. PAD is a type of peripheral vascular disease, which also includes carotid artery disease, renal artery disease, aortic disease, venous problems, and some other conditions, such as vasculitis.
People with peripheral artery disease (PAD) may or may not have symptoms. Because symptoms may be mild or even absent, many cases of PAD go undiagnosed.
Claudication comes from the Latin word "to limp." Claudication is leg cramp pain that occurs during exercise, especially walking. The pain is due to insufficient blood flow in the legs (caused by blocked arteries) to supply oxygen to the working muscles. Intermittent means the pain comes and goes. Intermittent claudication is the most typical symptom of PAD. About a third to a half of patients with PAD have this symptom.
Symptoms may be described as pain, ache, cramping, a sense of fatigue, or nonspecific discomfort that occurs with exercise. There is no discomfort while standing. Symptoms go away rapidly with rest, usually within a few minutes. At first, symptoms may only initially develop when walking uphill, walking faster, or walking longer distances.
Intermittent claudication symptoms are most common in the calf muscles. This is because the most frequently affected artery is the popliteal artery, which branches off from the femoral artery (the major artery in the thigh). The popliteal artery continues below the knee where it carries blood to the muscles in the calf and foot. Talk to your doctor about any leg or thigh pain you have.
Patients may experience leg pain in one leg or in both legs. Patients may also have fatigue or pain in the thighs and buttocks.
Critical Limb Ischemia
In advanced cases of PAD, the arteries are so blocked that even rest does not help. Leg pain that continues when lying down is called ischemic rest pain. It is caused by critical limb ischemia, the medical term for insufficient blood flow through arteries of the legs to the muscles and other tissues. Critical limb ischemia is a chronic condition and a very serious form of advanced PAD.
Typical symptoms of critical limb ischemia may include:
- Pain or tingling in the foot or toes, which may be so severe that even the weight of clothes or bed sheets cause or worsen the discomfort
- Pain worsens when the leg is elevated and improves by dangling legs over the side of the bed
People with critical limb ischemia are at risk for developing non-healing skin ulcers and gangrene (tissue death). In severe cases, amputation may be required.
Other signs of advanced PAD can include:
- Calf muscles that shrink (wither)
- Hair loss over the toes and feet
- Thick toenails
- Shiny, tight skin
- Painful non-bleeding ulcers on the feet or toes (usually black) that are slow to heal
Sometimes, blood clots form in the arteries in the legs, producing abrupt and severe symptoms (acute occlusion).
About 8 million American adults have peripheral artery disease (PAD), and the prevalence of the disease is increasing worldwide. Men and women are equally susceptible although women face a greater risk for limb loss. African-Americans have twice the risk for PAD as Caucasians. Between 12 to 20% of people over age 65 suffer from the condition.
PAD Risk Factors
The risk factors for PAD are the same as those for heart disease and stroke. Smoking and high cholesterol levels increase the risk for PAD progression in large blood vessels (such as the legs), while diabetes increases the risk for PAD in small blood vessels (such as the feet). Quitting smoking and controlling cholesterol and high blood pressure are the best ways to slow PAD progression.
The most important risk factors for PAD include:
- Smoking. Smoking is the number one risk factor for PAD, and smoking even a few cigarettes a day can interfere with PAD treatment. Smoking increases the risk for PAD by 2 to 25 times, with the danger being higher when other risk factors are present. Between 80 to 90% of patients with PAD are current or former smokers. Progression to a more critical state of illness is likely for patients who continue to smoke.
- Diabetes. People with type 2 diabetes have 3 to 4 times the normal risk for PAD and intermittent claudication. In fact, their risk for PAD is higher than their risk for heart disease. People with type 2 diabetes also tend to develop PAD at an earlier age and have more severe cases. Patients with both diabetes and PAD are at high risk for complications in the feet and ankles. Poor blood sugar (glucose) control increases the risk of developing PAD.
- Unhealthy cholesterol and lipid levels. The risk for PAD increases by 5 to 10% with every 10 mg/dL increase in total cholesterol levels. Levels of HDL ("good" cholesterol) below 40 mg/dL and high triglyceride levels also increase the risk for PAD. Prior guidelines suggest that LDL ("bad" cholesterol) levels should be kept below 100 mg/dL in all patients with PAD, and probably as low as 70 mg/dL when other risk factors are present (such as diabetes, coronary artery disease, smoking, and HDL below 40 mg/dL). Recently updated guidelines focus more on statin therapy and not target levels.
- Hypertension. High blood pressure, especially when combined with other cardiovascular risk factors, puts stress on the arteries and increases the chances for PAD. High blood pressure is generally considered to be a reading greater than 140 systolic and 90 diastolic (140/90 mm Hg). For people with diabetes or chronic kidney disease, blood pressure should not exceed 140/80. For some people with diabetes, especially younger patients, a systolic blood pressure goal of less than 130 mm Hg may be appropriate.
- Obesity and Physical Inactivity. Obesity and lack of exercise are risk factors for heart disease and diabetes, and contribute to increased risk for PAD. Increased physical activity is one of the most important measures for both preventing and treating PAD. Losing excess weight can help improve cholesterol, blood pressure, and other atherosclerotic disease risk factors.
- Family history of heart and artery disease. Genetic factors that cause specific lipid and cholesterol abnormalities may increase the risk for PAD.
- Age. PAD occurs more frequently in people over age 50 and particularly affects those ages 65 years and older.
- Ethnicity. African-Americans are at highest risk for PAD. They are twice as likely to develop PAD as Caucasians.
Peripheral artery disease (PAD) is greatly under-diagnosed. Many patients do not report symptoms, or may not even have symptoms.
People should be checked for PAD if they have leg pain during walking, or ulcers on their legs. Patients who may not have symptoms but who should be screened for PAD include those with coronary artery disease, diabetes, chronic kidney disease, or people who have had a previous stroke.
Doctors use the ankle-brachial index (ABI) to screen for PAD. The United States Preventive Services Task Force does not recommend routine ABI screening for PAD in older adults who do not have risk factors for PAD.
The doctor should check for high blood pressure, heart abnormalities, blockage(s) in the artery in the neck, and abdominal aneurysms. The doctor should also examine the skin of the legs and feet for color changes, ulcers, infection, or injuries, and check the pulse of the arteries in the leg.
The standard diagnostic and screening test for peripheral artery disease is a calculation called the ankle-brachial index. The procedure is done as follows:
- The doctor or technician measures the systolic blood pressure of both arms while the patient is lying down. (The systolic pressure is the "top" number in a blood pressure measurement. It is the force that blood exerts on the artery walls as the heart contracts to pump out the blood. For example, in a blood pressure reading of 120/80, 120 is the systolic number.)
- The doctor or technician then puts blood pressure cuffs on four different locations on each leg and passes a Doppler probe over arteries in the foot. The signal emitted from the strongest artery is recorded as the cuffs are inflated and deflated. This is the ankle's systolic pressure.
The doctor divides the systolic pressure in the ankle by the systolic pressure in the arm. The result is called the ankle-brachial index (ABI), also called ankle-arm pressure index (API).
What the results mean:
- ABI over 0.90. An ABI result from 1.00 to 1.40 is considered normal. Results from 0.91 to 0.99 are considered borderline. If results fall in the borderline range, the patient takes a treadmill test and another ABI measurement. If the API index drops after exercise, the doctor makes a diagnosis of peripheral artery disease.
- ABI 0.40 to 0.90. ABI measurements below 0.90 are considered abnormal. Measurements from 0.40 to 0.90 indicate mild-to-moderate impairment and symptoms such as leg pain.
- ABI less than 0.40. ABI measurements below 0.40 indicate very severe blockage in the leg arteries (critical limb ischemia) and a risk for gangrene. Patients should take precautions to avoid foot injuries, which can increase the risk for non-healing wounds and gangrene.
The ABI test is often followed by a treadmill test to find out how exercise affects the blood flow in your extremities. The treadmill test is also useful for determining the severity of the pain while walking and assessing the effectiveness of treatments.
Ultrasound imaging is used to provide an anatomic view of the arteries and report on blood velocity and flow characteristics. A duplex ultrasound combines traditional ultrasound with Doppler ultrasound. These tests can also help identify areas of arterial blockage and help doctors decide which patients may need surgical interventions.
Angiography, Magnetic Resonance Angiography (MRA), and Computed Tomography Angiography (CTA)
Before considering invasive procedures to treat peripheral artery disease, the surgeon needs a better understanding of which arteries are involved, how severe the blockage is, and the state of the blood vessels surrounding the blockage. In the past, invasive or conventional angiography was typically performed. This type of angiogram uses dye, which is injected through a catheter that is inserted in the groin or arm.
Magnetic resonance angiography (MRA) is a type of magnetic resonance imaging (MRI). It provides a non-invasive alternative to a traditional angiogram. The MRA uses a magnetic field and radiofrequency waves instead of radiation to provide pictures of arteries and blood vessels. Patients are given gadolinium (a contrast material) through an IV to improve the image quality. In many medical centers, MRA is considered almost or as accurate as invasive angiography and will frequently be the only test required.
Another technology called computed tomography angiography (CTA) uses x-rays to visualize blood flow in arteries throughout the body. This technique is also highly effective in diagnosing PAD.
Tests for Detecting Heart Disease
Patients with suspected PAD should have an electrocardiogram (ECG, EKG) and other tests that can detect heart problems.
Ruling Out Other Disorders with Similar Symptoms
A number of other tests may be ordered to rule out disorders with similar symptoms. Such conditions include:
- Spinal stenosis -- narrowing of the spinal canal causing leg or lower back pain
- Thrombophlebitis -- blood clots in the deep veins of the legs
- Peripheral neuropathy -- nerve damage in the legs and feet, usually in people with diabetes
- Night cramps in older people that are not due to problems in blood vessels
- Muscle entrapment of the arteries or kinks in the arteries in the leg -- typically occurs in young athletes
Coronary Artery Disease and Stroke
Patients with peripheral artery disease (PAD) have the same risk of death from heart events or stroke as people already diagnosed with heart disease. The risk increases as PAD gets worse. The worse the leg condition, the poorer the overall health of the patient.
If patients have blood clots and blockages in other arteries (brain, heart) as well as the legs, the risk for any vascular complication involving the heart, the brain, or the leg arteries increases much more.
Gangrene and Amputation
Severe advanced PAD can cause gangrene (tissue death) that leads to limb amputation. These conditions may result from critical limb ischemia (chronic blockage of arteries in the legs) or acute occlusion (sudden development of blood clot in a major artery of the leg.).
Poor Physical and Mental Functioning
Peripheral artery disease can significantly impair daily physical functioning. Leg pain can limit physical activity, cause unsteadiness, and increase the risk for falling. PAD may also cause erectile dysfunction and it is associated with mental decline.
There are 2 treatment goals for PAD and claudication.
- Manage the pain of intermittent claudication, improve functioning, and prevent PAD from getting worse so that gangrene does not occur.
- Reduce the risk for cardiovascular disease (heart attack and stroke).
Lifestyle changes, especially smoking cessation and exercise, are critical for every patient with PAD. Medication is often required to improve function and protect the heart. In very severe cases, surgery may be needed to improve blood flow.
Treatment for PAD also involves managing the medical conditions (diabetes, high cholesterol, and high blood pressure) that often accompany it.
Patients with diabetes (type 1 or type 2) need to strictly control their blood sugar (glucose) levels. Poor glycemic control is associated with vascular and circulation complications such as PAD. Patients should aim for an A1c level around 7%. The A1c test measures a patient's average blood sugar over the past 2 to 3 months. Patients with diabetes need to follow certain dietary restrictions. Many different types of medications are used to control blood sugar levels.
Managing Unhealthy Cholesterol and Lipid Levels
It is very important for people with PAD to keep their LDL ("bad" cholesterol) levels controlled. The latest guidelines recommend high-potency statin therapy to control cholesterol in patients with PAD. Unhealthy cholesterol levels are major contributors to atherosclerosis, the common factor in PAD and heart disease.
Patients should follow lifestyle principles to reduce unhealthy cholesterol levels including consuming a heart-healthy diet, engaging in regular physical activity (40 minutes of moderate to vigorous exercise 3 to 4 times a week), and maintaining a healthy body weight.
Managing High Blood Pressure
Most patients with PAD should aim for blood pressure less than 140/90 mm Hg. But patients with diabetes may need to have a lower systolic (top number) or diastolic (bottom number) goal. Ask your doctor what your target blood pressure goal should be.
Patients should be sure to follow dietary measures to reduce sodium (salt) and increase potassium intake. The DASH diet is a good example of a diet plan based on these principles.
Various medications are used to control high blood pressure (hypertension). There is some evidence that the best drugs for patients with high blood pressure and PAD may be angiotensin-converting-enzyme (ACE) inhibitors.
Patients who smoke should quit, and everyone should avoid second-hand smoke. Smoking is one of the primary risk factors for PAD and a major cause of complications. Quitting smoking may not make leg pain go away, at least not in the short term, but it certainly may keep blockages from getting worse. Continued smoking is a major reason why patients progress from milder forms of PAD to critical limb ischemia involving severe pain, skin ulcers, and possible amputation. Smoking cessation also reduces the risk to the heart.
Exercise is second only to avoiding tobacco as the most important lifestyle measure for treating, and preventing, PAD.
Exercise to Help the Heart. The benefits of regular moderate exercise for the heart are undisputed. People who maintain an active lifestyle have a much lower risk of developing heart disease than do sedentary people. According to the American Heart Association, patients with PAD who are physically active have death rates that are a third of those who are less physically active.
Exercise Training to Improve Blood Flow in the Legs. Exercise training improves blood flow in the legs and, in some cases, can work as well as medications and surgical procedures in increasing pain-free walking distance. To maintain benefits, exercise must be regular and consistent. A regular walking program, either outside or on a treadmill, is the best type of exercise for patients with PAD, and can significantly slow the rate of functional decline.
For patients with intermittent claudication who find that their leg cramps make it difficult to walk or participate in lower-extremity exercise, upper-body aerobic exercise can still provide benefits.
The goals of a heart-healthy diet are to:
- Reduce overall cholesterol levels and low-density lipoproteins (LDL or "bad" cholesterol), which are harmful to the heart
- Increase high-density lipoproteins (HDL or "good" cholesterol), which are beneficial for the heart
- Reduce other harmful lipids (fatty molecules) such as triglycerides and lipoprotein(a)
Any diet should also help keep blood pressure and weight under control. General guidelines for a heart-healthy diet include:
- Make vegetables, fruits, and whole grains the focus of your diet. Examples of whole grains include brown rice, quinoa, oats, barley, and millet.
- Include low-fat dairy products, poultry, fish, legumes (beans), nontropical vegetable oils, and nuts.
- Limit intake of sweets, sugar-sweetened beverages, and red meats.
- Avoid saturated fats (found mostly in animal products) and trans fatty acids (found in hydrogenated fats and many commercial baked products and fast-foods). Choose unsaturated fats (particularly omega-3 fatty acids found in vegetable and fish oils).
- When selecting proteins, choose soy protein, poultry, and fish over meat.
- Weight control, quitting smoking, and exercise are essential companions of any diet program.
While vitamin deficiencies may be associated with PAD and heart disease, vitamin supplements have not been proven to reduce the risk for heart-related conditions. Low levels of vitamin D are linked to an increased risk of PAD, and many older Americans are deficient in this vitamin. More research is needed to determine if vitamin D supplements protect against PAD.
Deficiencies in the B vitamins folate and B12 are associated with elevated levels of homocysteine, an amino acid that may be a marker for increased risk for heart disease and PAD. However, while vitamin supplementation lowers homocysteine levels, it has no effect on heart disease outcomes. Similarly, vitamin E and other multivitamin supplements do not help PAD symptoms.
Herbs and Supplements
Generally, manufacturers of herbal remedies and dietary supplements do not need FDA approval to sell their products. Just like a drug, herbs and supplements can affect the body's chemistry, and therefore have the potential to produce side effects that may be harmful. There have been a number of reported cases of serious and even lethal side effects from herbal products. Always check with your health care provider before using any herbal remedies or dietary supplements.
Gingko biloba is an herbal remedy reported to have blood-thinning properties. However, studies have shown it does not provide any benefit for patients with PAD or intermittent claudication. Although the risks for gingko appear to be low, there is an increased risk for bleeding at high doses and harmful interaction with high doses of anti-clotting medications. This is particularly important because patients with PAD often use these types of medications. Commercial gingko preparations have also been reported to contain colchicine, a chemical that can be harmful in pregnant women and people with kidney or liver problems.
Medications for peripheral artery disease (PAD) help prevent blood clots and reduce the risk for heart attack and stroke.
Aspirin and Other Antiplatelet Drugs
Antiplatelet drugs such as aspirin prevent blood clots. Most patients with peripheral artery disease receive antiplatelet medication. For the most part, this recommendation is made to prevent future death from heart attack or stroke. Antiplatelet drugs may or may not provide benefit for PAD symptoms and progression.
Aspirin is usually the recommended first-line choice. However, recent studies have indicated that aspirin may not have much benefit in preventing heart attack or stroke in patients who have PAD without also having heart disease.
Clopidogrel (Plavix, generic) is another antiplatelet drug that is sometimes used as an alternative to aspirin.
Vorapaxar (Zontivity) is a new type of antiplatelet drug approved to lower risk of heart attack, stroke, or heart disease death for patients who have peripheral artery disease or those who have had a heart attack. It is the first in a new class of drugs called protease-activated receptor-1 (PAR-1) antagonists. Patients who have had a stroke should not use this drug because the risk of bleeding is too great.
Research indicates that adding an anticoagulant drug, such as warfarin (Coumadin, generic), to antiplatelet therapy does not help prevent heart complications of PAD, and can increase the risks for life-threatening bleeding.
All antiplatelet drugs can increase the risks for bleeding.
Statins are the most common type of medication used to help lower LDL cholesterol and improve lipid profiles. Cholesterol management is a very important part of PAD treatment. Current guidelines from the American College of Cardiology and the American Heart Association recommend statin therapy for all patients with PAD.
Statin drugs include:
- Lovastatin (Mevacor, generic)
- Pravastatin (Pravachol, generic)
- Simvastatin (Zocor, generic)
- Fluvastatin (Lescol)
- Atorvastatin (Lipitor, generic)
- Rosuvastatin (Crestor)
- Pitavastatin (Livalo)
ACE inhibitors are a type of drug used to treat high blood pressure. These drugs block the effects of the angiotensin-renin-aldosterone system, which is associated with many harmful effects on the heart and blood vessels. They are important drugs for patients with PAD and diabetes who also have high blood pressure.
In addition to heart protection, ACE inhibitors may help reduce pain that patients experience when walking. The ACE inhibitor ramipril (Altace, generic) is often specifically recommended for patients with symptomatic peripheral artery disease. Studies indicate that in addition to reducing the risk of cardiovascular events, ramipril may help improve walking ability and quality of life in patients with intermittent claudication.
ACE inhibitors include:
- Ramipril (Altace, generic)
- Captopril (Capoten, generic)
- Enalapril (Vasotec, generic)
- Quinapril (Accupril, generic)
- Benazepril (Lotensin, generic)
- Perindopril (Aceon, generic)
- Lisinopril (Prinivil, Zestril, generic)
Phosphodiesterase Inhibitors for Intermittent Claudication
Phosphodiesterase inhibitors are drugs that help improve blood flow. They may be prescribed to treat intermittent claudication.
Cilostazol. Cilostazol (Pletal, generic) is used to treat disabling intermittent claudication. A number of studies have reported that the drug helps improve walking distance and quality of life. It also helps improve HDL and triglyceride levels. Cilostazol works better than pentoxifylline, the first drug approved for claudication. However, it is expensive, and currently recommended only for patients with moderate-to-severe intermittent claudication who do not respond to aspirin or less costly treatments.
Common side effects include headache, swelling in the limbs, and stomach problems such as diarrhea and flatulence (gas). It does not appear to have bad effects on the liver or kidney. Similar drugs can have serious side effects in patients with heart failure, so patients with heart failure should avoid cilostazol.
Pentoxifylline. Pentoxifylline (Trental, generic) reduces the sticky properties of blood cells, improving blood flow. It is approved in the U.S. for managing claudication, although doctors do not recommend its routine use. Studies regarding the drug's effectiveness have been mixed. Some studies have reported a small effect on walking ability; another found the drug significantly improved walking distance. Other research has found that the drug does not work any better than a dummy pill (placebo). The most common side effects include headache, nausea, heartburn, flatulence (gas), dizziness, blurred vision, and flushing.
In severe cases of PAD, surgery may be needed to open blocked blood vessels. Many different types of surgical procedures can be performed. They include open bypass procedures, which connect an artery before the location of the obstruction to an artery below the obstruction, or minimally invasive endovascular techniques such as angioplasty and stenting. The location of the lesions and how many other risk factors and illnesses patients have often determine which procedure is chosen.
Surgery is generally performed for claudication that has become disabling despite full medical and exercise therapy. Surgery may also be necessary for patients with rest pain, and to save a limb when a patient develops critical limb ischemia and is in danger of amputation.
Leg Bypass Surgery
For many years, leg bypass surgery was the main type of surgery used for extensive PAD. This procedure involves the creation of a tube (graft) that acts as a new blood vessel. Grafts can be made from synthetic material (artificial vein) or from a vein taken from a different location in the patient's leg (natural vein). The graft reroutes blood flow in the leg, around the blocked artery. Possible bypass connections between arteries include aorta to iliac arteries, aorta to femoral arteries, and bypass between the femoral artery and popliteal, tibial, and peroneal arteries.
Artificial veins tend to pose a much higher risk for blood clots, and the consequences of re-blockage are must more severe than when the natural vein recloses. To keep the artificial vein open, oral anti-clotting drugs such as aspirin or warfarin may be used. (Such drugs do not work with natural vein bypass.)
In general, less invasive procedures, such as balloon angioplasty and stenting, are now more frequently performed.
Percutaneous Transluminal Angioplasty
Percutaneous transluminal angioplasty (PTA) is an approach that has several variations. The object of the procedure is to open the blocked blood vessels that are causing intermittent claudication. Angioplasty is being increasingly used in place of leg bypass surgery, especially in patients who have other medical conditions.
The PTA procedure requires only a local anesthetic. Patients can return to normal activity in 24 to 48 hours. Complication rates are low. The effects are not permanent, but the procedure can be repeated with minimal risk.
Anticoagulants (such as warfarin or heparin) and antiplatelets (such as aspirin) may be used to prevent blood clots occurring during surgery. All of these drugs increase the risk for bleeding.
Thrombolytic drugs such as alteplase (Activase) and reteplase (Retavase) may be used intravenously before, during, or after angioplasty if a blood clot is present. Such drugs are commonly called "clot-busters." They break up existing clots, and may be used in cases of acute vascular occlusion (the sudden development of a blood clot).
Balloon Angioplasty. The standard procedure is balloon angioplasty. A thin tube is inserted through an artery in the groin and passed through the blocked artery. A wire is threaded through the tube. A deflated balloon is passed over the wire to the blockage. When inflated, it opens the artery.
Because balloon angioplasty poses a risk for reclosure of the artery, various other procedures are used or are being investigated.
Stenting. Re-blockage of the blood vessels from blood clotting, even long after surgery, is a major complication. To help prevent this complication, and repeat surgery, a tiny expandable metal mesh tube (stent) is often used along with angioplasty. However, even with stents, some patients experience new blockages within a year of surgery. Some angioplasties are performed with a drug-eluting stent, which is coated with the drug paclitaxel to help prevent artery blockages.
Drug-eluting stents may not be recommended for patients who had recent heart surgery, or women who are nursing or pregnant. Patients who receive a drug-eluting stent may need to take blood thinning drugs for at least several months.
- www.nhlbi.nih.gov -- National Heart, Lung, and Blood Institute
- www.heart.org-- American Heart Association
- www.cardiosource.org -- American College of Cardiology
- www.diabetes.org -- American Diabetes Association
- www.vasculardisease.org -- Vascular Disease Foundation
- www.sirweb.org -- Society of Interventional Radiology
Aboyans V, Criqui MH, Abraham P, et al. Measurement and interpretation of the ankle-brachial index: a scientific statement from the American Heart Association. Circulation. 2012;126(24):2890-2909.
Ahimastos AA, Walker PJ, Askew C, et al. Effect of ramipril on walking times and quality of life among patients with peripheral artery disease and intermittent claudication: a randomized controlled trial. JAMA. 2013;309(5):453-460.
Alonso-Coello P, Bellmunt S, McGorrian C, et al. Antithrombotic therapy in peripheral artery disease: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012;141(2 Suppl):e669S-e690S.
Anderson JL, Halperin JL, Albert N, et al. Management of patients with peripheral artery disease (compilation of 2005 and 2011 ACCF/AHA Guideline Recommendations): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2013;61(14):1555-1570.
Berger JS, Krantz MJ, Kittelson JM, Hiatt WR. Aspirin for the prevention of cardiovascular events in patients with peripheral artery disease: a meta-analysis of randomized trials. JAMA. 2009;301(18):1909-1919.
Collins R, Burch J, Cranny G, et al. Duplex ultrasonography, magnetic resonance angiography, and computed tomography angiography for diagnosis and assessment of symptomatic, lower limb peripheral arterial disease: systematic review. BMJ. 2007;334(7606):1257.
Creager MA, Libby P. Peripheral arterial disease. In: Bonow RO, Mann DL, Zipes DP, Libby P, eds. Braunwald's Heart Disease: A Textbook of Cardiovascular Medicine. 9th ed. Saunders; 2012:1338-1358.
Eckel RH, Jakicic JM, Ard JD, et al. 2013 AHA/ACC Guideline on Lifestyle Management to Reduce Cardiovascular Risk: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2014;63(25 Pt B):2960-2984.
Fleg JL, Forman DE, Berra K, et al. Secondary prevention of atherosclerotic cardiovascular disease in older adults: a scientific statement from the American Heart Association. Circulation. 2013;128(22):2422-2446.
Fowkes FG, Price JF, Stewart MC, et al. Aspirin for prevention of cardiovascular events in a general population screened for a low ankle brachial index: a randomized controlled trial. JAMA. 2010;303(9):841-848.
Fowkes FG, Rudan D, Rudan I, et al. Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis. Lancet. 2013;382(9901):1329-1340.
Hamburg NM, Balady GJ. Exercise rehabilitation in peripheral artery disease: functional impact and mechanisms of benefits. Circulation. 2011;123(1):87-97.
Hennion DR, Siano KA. Diagnosis and treatment of peripheral arterial disease. Am Fam Physician. 2013;88(5):306-310.
Hirsch AT, Allison MA, Gomes AS, et al. A Call to action: women and peripheral artery disease: a scientific statement from the American Heart Association. Circulation. 2012;125(11):1449-1472.
Joosten MM, Pai JK, Bertoia ML, et al. Associations between conventional cardiovascular risk factors and risk of peripheral artery disease in men. JAMA. 2012;308(16):1660-1667.
McDermott MM, Ades P, Guralnik JM, et al. Treadmill exercise and resistance training in patients with peripheral arterial disease with and without intermittent claudication: a randomized controlled trial. JAMA. 2009;301(2):165-174.
Met R, Bipat S, Legemate DA, Reekers JA, Koelemay MJ. Diagnostic performance of computed tomography angiography in peripheral arterial disease: a systematic review and meta-analysis. JAMA. 2009;301(4):415-424.
Moyer VA; U.S. Preventive Services Task Force. Screening for peripheral artery disease and cardiovascular disease risk assessment with the ankle-brachial index in adults: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2013;159(5):342-348.
Olin JW, Allie DE, Belkin M, et al. ACCF/AHA/ACR/SCAI/SIR/SVM/SVN/SVS 2010 performance measures for adults with peripheral artery disease: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Performance Measures, the American College of Radiology, the Society for Cardiac Angiography and Interventions, the Society for Interventional Radiology, the Society for Vascular Medicine, the Society for Vascular Nursing, and the Society for Vascular Surgery (Writing Committee to Develop Clinical Performance Measures for Peripheral Artery Disease). J Am Coll Cardiol. 2010;56(25):2147-2181.
Smith SC Jr, Benjamin EJ, Bonow RO, et al. AHA/ACCF secondary prevention and risk reduction therapy for patients with coronary and other atherosclerotic vascular disease: 2011 update: a guideline from the American Heart Association and American College of Cardiology Foundation endorsed by the World Heart Federation and the Preventive Cardiovascular Nurses Association. J Am Coll Cardiol. 2011;58(23):2432-2446.
Stone NJ, Robinson J, Lichtenstein AH, et al. 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2014;63(25 Pt B):2889-2934.
Warfarin Antiplatelet Vascular Evaluation Trial Investigators, Anand S, Yusuf S, et al. Oral anticoagulant and antiplatelet therapy and peripheral arterial disease. N Engl J Med. 2007;357(3):217-227.
Review Date: 6/30/2014
Reviewed By: Michael A. Chen, MD, PhD, Associate Professor of Medicine, Division of Cardiology, Harborview Medical Center, University of Washington Medical School, Seattle, Washington. Also reviewed by David Zieve, MD, MHA, Isla Ogilvie, PhD, and the A.D.A.M. Editorial team.